PG-530742 / Procter & Gamble  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
PG-530742 / Procter & Gamble
NCT00041756: Efficacy and Safety of PG-530742 in the Treatment of Mild to Moderate Knee Osteoarthritis

Completed
2
395
Europe
PG-530742, Placebo, 50 mg PG-530742, 100 mg PG-530742, 200 mg PG-530742
Procter and Gamble
Osteoarthritis, Knee
02/04
02/04
NCT00067236: Study of Oral PG-116800 Following a Heart Attack

Completed
2
253
US, Canada, Europe
PG-116800 (given as PG-530742), Placebo tablet
Procter and Gamble
Myocardial Infarction, Heart Failure, Heart Enlargement
12/04
12/04

Download Options